NeuBase Therapeutics Inc (NBSE): He was probably adding up the difference...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	605
Posts	71253
Boards Moderated	2
Alias Born	09/27/2006

Backstabbed

Re: bjl post# 106

Friday, 09/01/2023 6:08:55 PM

Friday, September 01, 2023 6:08:55 PM

He was probably adding up the difference from filing to filing. Who knows and who cares.

What we know is that the filing is showing an ownership of 26.2% by Symetrix Corp

… And they stated that they will be adding more!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent NBSE News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/03/2024 08:08:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 08:29:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:59:01 PM
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 05/16/2024 02:07:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:25:31 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 11:30:24 AM
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq • GlobeNewswire Inc. • 04/05/2024 08:05:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:01:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:01:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 01:00:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 11:15:15 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 12:00:12 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/28/2023 11:15:19 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 11:15:44 AM
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance • GlobeNewswire Inc. • 11/27/2023 02:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:11:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 10:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 11:30:13 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 12:00:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:10:36 PM
Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/21/2023 12:42:52 AM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/20/2023 09:28:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 08:32:12 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/18/2023 08:20:48 PM

More NBSE News

InvestorsHub NewsWire

FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM

Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM

Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM

IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover